Mesenchymal stem cell therapy for liver fibrosis need “partner”: Results based on a meta-analysis of preclinical studies

doi:10.3748/wjg.v30.i32.3766

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 32

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (187)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

HTML

117

Figures (1-6)

Tables (1-1)

Sum=171

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=4

Aug 28, 2024 (publication date) through Aug 29, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Aug 28, 2024; 30(32): 3766-3782
Published online Aug 28, 2024. doi: 10.3748/wjg.v30.i32.3766

Full Size Figure Download Figure

Figure 6 Diagram of the mechanism of mesenchymal stem cell therapy for liver fibrosis. MSCs: Mesenchymal stem cells; HSCs: Hepatic stellate cells.

Citation: Xu Y, Wang XS, Zhou XL, Lu WM, Tang XK, Jin Y, Ye JS. Mesenchymal stem cell therapy for liver fibrosis need “partner”: Results based on a meta-analysis of preclinical studies. World J Gastroenterol 2024; 30(32): 3766-3782
URL: https://www.wjgnet.com/1007-9327/full/v30/i32/3766.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i32.3766